Q BioMed Inc. Discusses The Commercialization of Its FDA Approved Metastatic Bone Pain Drug with The Stock Day Podcast episode artwork

EPISODE · Apr 27, 2020 · 10 MIN

Q BioMed Inc. Discusses The Commercialization of Its FDA Approved Metastatic Bone Pain Drug with The Stock Day Podcast

from Stock Day Media · host Stock Day Media

The Stock Day Podcast welcomed Q BioMed Inc. (QBIO)(“the Company”), a biotech acceleration and commercial stage company focused on licensing and acquiring undervalued biomedical assets in the healthcare sector. CEO of the Company, Denis Corin, joined Stock Day host Everett Jolly. Advertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy

Episode metadata supplied by the publisher feed · Published Apr 27, 2020

Embed this episode

Ready to play

Q BioMed Inc. Discusses The Commercialization of Its FDA Approved Metastatic Bone Pain Drug with The Stock Day Podcast

0:00 10:31

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Frequently Asked Questions

How long is this episode of Stock Day Media?

This episode is 10 minutes long.

When was this Stock Day Media episode published?

This episode was published on April 27, 2020.

Can I download this Stock Day Media episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!